Literature DB >> 3840535

Potentiation of the anthelmintic activity of oxfendazole by parbendazole.

D R Hennessy, E Lacey, R K Prichard, J W Steel.   

Abstract

The ability of parbendazole (PBZ) to potentiate co-administered oxfendazole (OFZ) was investigated. Administration of a range (1.35-36.0 mg/kg) of doses of PBZ with 4.53 mg OFZ/kg demonstrated that significant potentiation occurred at 4.5 mg PBZ/kg. At 4.5 mg PBZ/kg, the area under the plasma OFZ concentration curve was about twice that obtained from oral administration of OFZ alone. When tested against benzimidazole-resistant Haemonchus contortus and Trichostrongylus colubriformis, the mixture of 4.5 mg PBZ + 4.53 mg OFZ/kg was significantly more effective than 4.53 mg OFZ/kg alone, and PBZ alone showed no activity against these resistant nematodes. The demonstration of PBZ-OFZ potentiation has indicated a means of obtaining a more effective use of currently available anthelmintics in the treatment of helminthiasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840535     DOI: 10.1111/j.1365-2885.1985.tb00956.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  13 in total

1.  Influence of diet type and pretreatment fasting on the disposition kinetics of albendazole in sheep.

Authors:  D Singh; P K Sanyal; C P Swarnkar; F A Khan; P S Bhagwan
Journal:  Vet Res Commun       Date:  1999-06       Impact factor: 2.459

2.  Comparative disposition kinetics of albendazole in sheep following oral and intraruminal administration.

Authors:  C P Swarnkar; P K Sanyal; D Singh; F A Khan; P S Bhagwan
Journal:  Vet Res Commun       Date:  1998-12       Impact factor: 2.459

3.  The efficacy and pharmacokinetics of long-term low-level intraruminal administration of triclabendazole in buffalo with induced fasciolosis.

Authors:  P K Sanyal; S C Gupta
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

4.  The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.

Authors:  P K Sanyal
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

5.  Some pharmacokinetic parameters of oxfendazole in sheep.

Authors:  A L Soraci; N Mestorino; J O Errecalde
Journal:  Vet Res Commun       Date:  1997-05       Impact factor: 2.459

6.  Influence of subclinical nematodosis on the kinetic disposition of fenbendazole in buffaloes.

Authors:  A C Mathur; P K Sanyal; S Sarkar
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

7.  Effects of diet and species on the pharmacokinetics of fenbendazole in cattle.

Authors:  M R Knox; J W Steel
Journal:  Vet Res Commun       Date:  1997-01       Impact factor: 2.459

8.  A comparison of plasma metabolite levels in goats and sheep during continuous low-level administration of fenbendazole.

Authors:  M R Knox; J W Steel; D N Ali; L F Le Jambre
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

9.  The uptake of fenbendazole by cattle and buffalo following long-term low-level administration in urea-molasses blocks.

Authors:  P K Sanyal; D K Singh
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

10.  Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.

Authors:  N Mestorino; E A Formentini; M F Lucas; C Fernandez; P Modamio; E Mariño Hernández; J O Errecalde
Journal:  Vet Res Commun       Date:  2007-04-25       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.